Gene editing for neurodegenerative diseases-A review

Gene editing for neurodegenerative diseases-A review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Détails bibliographiques
Auteur principal:	Sharna, Anika Islam
Autres auteurs:	Chowdhury, Namara Mariam
Format:	Thèse
Langue:	English
Publié:	Brac University 2023
Sujets:	Neurodegenerative disease (ND) Alzheimer’s disease (AD) Parkinson’s disease (PD) Amyotrophic Lateral Sclerosis (ALS) Huntington’s disease (HD) Frontotemporal Dementia (FD) Nervous system > Diseases. Gene editing > Technological innovations.
Accès en ligne:	http://hdl.handle.net/10361/19303

Documents similaires

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
par: Dey, Manashi
Publié: (2024)

Potential treatments for epigenetic dysregulation in neurological diseases
par: Zaman, Rubaiyat
Publié: (2024)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
par: Mostofa, Golam
Publié: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
par: Karmaker, Swastika
Publié: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
par: Key, Nasrin Sultana
Publié: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
par: Shehab, Habibul Mohsin
Publié: (2024)

Role of circular RNA in neurological disease
par: Salsabil, Labiba
Publié: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
par: Islam, Md. Rakibul
Publié: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
par: Bakar, Osama Bin Abu
Publié: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
par: Mahee, Sadique Abdal
Publié: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
par: Alim, Abdul
Publié: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
par: Jahan, Nusrat
Publié: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
par: Annee, Israt Jahan
Publié: (2023)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
par: Aana, Afsara Sumon
Publié: (2021)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
par: Chowdhury, Sariya Uzrat
Publié: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
par: Ferdous, Labiba
Publié: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
par: Afsana, Nourin
Publié: (2022)

Harnessing exosomes as a drug delivery system for neurodegenerative diseases
par: Ferdous, Farhana
Publié: (2022)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
par: Tasneem, Sadia
Publié: (2021)

A review of Cell-penetrating peptide mediated drug delivery to the brain
par: Tisha, Zarin Tasnim
Publié: (2024)

Emerging therapies of Alzheimer’s disease: a comprehensive review
par: Tasin, Md Abtahi
Publié: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
par: Rahman, Quazi Ashikur, et autres
Publié: (2022)

To control site-specific skin gene expression, autocrine mimics paracrine canonical Wnt signaling and Is activated ectopically in skin disease
par: Kim, Dongwon, et autres
Publié: (2016)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
par: Rawshan, A. E. Maisha
Publié: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
par: Saha, Bithi Rani
Publié: (2023)

Treatment options of Parkinson’s disease: How far we are from the cure?
par: Afreen, Nuraia
Publié: (2021)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
par: Chowdhury, Amal
Publié: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
par: Tamanna, Mst. Taskia
Publié: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
par: Hassan, Md. Muhtaz
Publié: (2020)

Infection and communicable diseases /
par: Brettle, Raymond Patrick
Publié: (1984)

The Aids booklet /
par: Cox, Frank D.
Publié: (1999)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
par: Aziz, Farhin
Publié: (2019)

Alzheimer's disease and marriage : an intimate account /
par: Wright, Lore K.
Publié: (1993)

Can bacteria fly? - bacteriological assessment of common fly (Musca domestica) as a potential carrier for public health epidemics
par: Tabassum, Nuzhat, et autres
Publié: (2024)

Detection of amyotrophic lateral sclerosis using signal processing and machine learning
par: Ali, Zohair Mehtab
Publié: (2020)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
par: Asaduzzaman, et autres
Publié: (2021)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
par: Nayeem, Abdullah Al
Publié: (2021)